Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer

Name: Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

stage ii oropharyngeal squamous cell carcinoma ajcc v6 and v7, stage iii oropharyngeal squamous cell carcinoma ajcc v7, stage iva oropharyngeal squamous cell carcinoma ajcc v7

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256878
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.